The EGF Receptor Conundrum

Por Wilken, Jason A., Baron, Andre T., Maihle, Nita J.
Publicado em 2010

Identification of Immunoreactive Regions of Homology between Soluble Epidermal Growth Factor Receptor (sEGFR) and α5-Integrin()

Por Wilken, Jason A., Baron, Andre T., Foty, Ramsey A., McCormick, Daniel J., Maihle, Nita J.
Publicado em 2011

Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists

Por Martin, Frances M., Harris, Andrew M., Rowland, Randall G., Conner, William, Lane, Matthew, Durbin, Erik, Baron, Andre T., Kyprianou, Natasha
Publicado em 2008

Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment

Por Ma, Wei, Ma, Jing, Xu, Jie, Qiao, Chong, Branscum, Adam, Cardenas, Andres, Baron, Andre T., Schwartz, Peter, Maihle, Nita J., Huang, Yingqun
Publicado em 2013

EGFR/HER-targeted therapeutics in ovarian cancer

Por Wilken, Jason A, Badri, Tayf, Cross, Sarah, Raji, Rhoda, Santin, Alessandro D, Schwartz, Peter, Branscum, Adam J, Baron, Andre T, Sakhitab, Adam I, Maihle, Nita J
Publicado no Future Med Chem (2012)

Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma

Por Cosentino-Boehm, Abby L., Lafky, Jacqueline M., Greenwood, Tammy M., Kimbler, Kimberly D., Buenafe, Marites C., Wang, Yuxia, Branscum, Adam J., Yang, Ping, Maihle, Nita J., Baron, Andre T.
Publicado no Diagnostics (Basel) (2013)

A Phase II Evaluation of Gefitinib in the Treatment of Persistent or Recurrent Endometrial Cancer: A Gynecologic Oncology Group Study

Por Leslie, Kimberly K., Sill, Michael W., Fischer, Edgar, Darcy, Kathleen M., Mannel, Robert S., Tewari, Krishnansu S., Hanjani, Parviz, Wilken, Jason A., Baron, Andre T., Godwin, Andrew K., Schilder, Russell J., Singh, Meenakshi, Maihle, Nita J.
Publicado em 2013